12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

• Bellerophon Therapeutics BLPH shares moved upwards by 8.12% to $3.66 during Thursday's after-market session. The market value of their outstanding shares is at $34.7 million.


• OPKO Health OPK stock increased by 5.44% to $3.87. OPKO Health's trading volume hit 414.4K shares by close, accounting for 13.56% of its average volume over the last 100 days. The company's market cap stands at $2.6 billion. The company's, Q3 earnings came out today.


• Xenetic Biosciences XBIO shares moved upwards by 4.16% to $1.75. The company's market cap stands at $16.9 million.


• Ontrak OTRKP stock moved upwards by 3.82% to $12.2.


• Idera Pharmaceuticals IDRA stock rose 3.27% to $0.89. The company's market cap stands at $46.8 million.


• SINTX Technologies SINT stock moved upwards by 3.25% to $1.27. The market value of their outstanding shares is at $31.3 million.


 

Losers

• Pulmatrix PULM stock declined by 8.0% to $0.92 during Thursday's after-market session. Today's trading volume for this security ended up closing at 260.0K shares, which is 93.47 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $51.7 million.


• Travere Therapeutics TVTX stock decreased by 5.98% to $25.0. Trading volume for this security closed at 75.6K, accounting for 6.41% of its average full-day volume over the last 100 days. The company's market cap stands at $1.5 billion. As per the news, the Q3 earnings report came out today.


• LeMaitre Vascular LMAT shares decreased by 4.61% to $53.66. The company's market cap stands at $1.1 billion. The company's, Q3 earnings came out today.


• Kiromic BioPharma KRBP shares decreased by 4.39% to $2.18. The company's market cap stands at $33.6 million.


• MannKind MNKD stock fell 3.96% to $4.61. MannKind's trading volume hit 206.7K shares by close, accounting for 7.14% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.


• Cellectar Biosciences CLRB shares declined by 3.87% to $0.84. The market value of their outstanding shares is at $51.2 million.
  See Also: www.benzinga.com/money/best-healthcare-stocks/